Advertisement

The National Center on Birth Defects and Developmental Disabilities

Past, Present, and Future
      The National Center on Birth Defects and Developmental Disabilities (NCBDDD) was established in April 2001 as a result of The Children's Health Act of 2000.

      H.R. 4365: Children's Health Act of 2000 Public Law No: 106-310.

      The supporters of the center's creation wanted to raise the visibility of child health and disability at the CDC. From its inception, the NCBDDD included the established programs in birth defects, genetic disorders, developmental disabilities and disabilities and health, with a more than 30-year history in surveillance, research, and public health practice, including the training of public health professionals in these respective fields.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. H.R. 4365: Children's Health Act of 2000 Public Law No: 106-310.

        • Atrash H.K.
        • Parker C.S.
        The public health response to blood disorders.
        Am J Prev Med. 2010; 38: S451-S456
        • CDC
        National Center on Birth Defects and Developmental Disabilites (NCBDDD): NCBDDD 10 years of Service (2011).
        • Williams W.J.
        • Mai C.T.
        • Edmonds L.D.
        • et al.
        Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the U.S..
        Teratology. 2002; 66: 33-39
        • CDC
        Spina bifida and anencephaly before and after folic acid mandate—United States, 1995-1996 and 1999-2000.
        MMWR. 2004; 53: 362-365
        • Oakley G.P.
        Folic acid-preventable spina bifida: a good start but much to be done.
        Am J Prev Med. 2010; 38: 569-570
        • Reefhuis J.
        • Honein M.A.
        • Whitney C.G.
        • et al.
        Risk of bacterial meningitis in children with cochlear implants.
        N Engl J Med. 2003; 349: 435-445
        • CDC
        Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices.
        MMWR. 2003; 52: 739-740
      2. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism.
        DHHS, Washington DC2008
        • Beckman M.G.
        • Grosse S.D.
        • Kenney K.M.
        • Grant A.M.
        • Atrash H.K.
        Developing public health surveillance for deep vein thrombosis and pulmonary embolism.
        Am J Prev Med. 2011; 41: S428-S434
        • Daniel K.L.
        • Prue C.
        • Taylor M.K.
        • Thomas J.
        • Scales M.
        Learn the signs.
        Pub Health Rep. 2009; 123: e11-e16
      3. The Surgeon General's call to action to improve the health and wellness of persons with disabilities.
        DHHS, Washington DC2005
      4. The Future of Disability in America.
        IOM, Washington DC2007
        • Johnson K.
        • Posner S.F.
        • Biermann J.
        • et al.
        Recommendations to improve preconception health and health care—U.S..
        MMWR. 2006; 55: 1-23
        • IOM
        Clinical preventive services for women: closing the gaps.
        National Academies Press, Washington DC2011
        • Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators
        • CDC
        Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, six sites, U.S., 2000.
        MMWR. 2007; 56: 1-11
        • Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators
        • CDC
        Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, U.S., 2006.
        MMWR. 2009; 58: 1-20
        • Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators
        • CDC
        Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 Sites, U.S., 2008.
        MMWR. 2012; 61: 1-18
        • Alwan S.
        • Reefhuis J.
        • Rasmussen S.A.
        • Friedman J.M.
        • National Birth Defects Prevention Study
        Patterns of antidepressant medication use among pregnant women in a U.S. population.
        J Clin Pharmacol. 2011; 51: 264-270
        • Broussard C.S.
        • Rasmussen S.A.
        • Reefhuis J.
        • et al.
        • National Birth Defects Prevention Study
        Maternal treatment with opioid analgesics and risk for birth defects.
        Am J Obstet Gynecol. 2011; 204: 314.e1-314.e11
        • Lin S.
        • Munsie J.P.
        • Herdt-Losavio M.L.
        • Bell E.
        • Druschel C.
        • Romitti P.A.
        • Olney R.
        Maternal asthma medication use and the risk of gastroschisis.
        Am J Epidemiol. 2008; 168: 73-79
        • Manco-Johnson M.J.
        • Abshire T.C.
        • Shapiro A.D.
        • et al.
        Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
        N Engl J Med. 2007; 357: 535-544
        • Beckman M.G.
        • Hooper W.C.
        • Critchley S.E.
        • Ortel T.L.
        Venous thromboembolism: a public health concern.
        Am J Prev Med. 2010; 38: S495-S501